Navigation Links
MiMedx Group Receives HCPCS C-Code from Medicare for EpiFix® Reimbursement
Date:12/5/2011

KENNESAW, Ga., Dec. 5, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has received a transitional pass-through status C-Code from the Centers for Medicare & Medicaid Services ("CMS") for its EpiFix® Amniotic Membrane Allograft.  EpiFix® has been assigned a pass-through status under Medicare's outpatient prospective payment system ("OPPS") effective January 1, 2012. This code will facilitate reimbursement for the application of EpiFix® when used in Medicare patients with chronic wounds. This code will cover the grafts used in treating Medicare patients with dermal wounds in the hospital operating room or a freestanding surgical suite.

Parker H. "Pete" Petit, Chairman and CEO said, "We are very pleased with the CMS decision and their recognition of the therapeutic and financial value that our unique allograft brings to these patients. By making EpiFix® eligible for coverage and reimbursement for the Medicare beneficiaries, these individuals will be able to receive the benefits of this treatment for wounds."

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix®, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion® process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MiMedx Group Announces Third Quarter 2011 Results
2. MiMedx Groups EpiFix® Receives American Podiatric Medical Association Seal of Approval
3. MiMedx Group Partners With Affirmative Solutions
4. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
5. MiMedx Announces Launch of AmnioFix™ Nerve Wrap
6. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
7. MiMedx Group, Inc. Announces Release Date for First Quarter Results
8. MiMedx Completes Acquisition of Surgical Biologics
9. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
10. MiMedx Announces Agreement to Acquire Surgical Biologics
11. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... AUGUSTA, Ga. , March 27, 2015  Holographic ... innovator in the field of holographic medical imaging, is ... of its Kickstarter campaign. Launching on April 20 th ... Voxbox and Voxbox Pro. The 8-inch and 22-inch displays ... at home for the first time. In addition to ...
(Date:3/27/2015)... , March 27, 2015   Cypher Genomics, ... announced new data showing that, compared to a ... technology provided highly equivalent interpretations of whether certain ... did so in a fraction of the time. ... for more comprehensive genetic analysis in non-invasive prenatal ...
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... AUSTIN, Texas, April 27, 2011 Hanger Orthopedic Group, Inc. ... million for the quarter ended March 31, 2011, an increase ... first quarter of 2010.  Adjusted diluted earnings per share, which ... $0.19 for the first quarter of 2011, an 18.8% increase ...
... N.Y. and BERLIN, April 27, 2011 Regeneron ... today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic ... macular edema due to central retinal vein occlusion (CRVO).  The ... the similarly designed Phase 3 COPERNICUS study that were announced ...
Cached Medicine Technology:Hanger Orthopedic Group Reports First Quarter Results 2Hanger Orthopedic Group Reports First Quarter Results 3Hanger Orthopedic Group Reports First Quarter Results 4Hanger Orthopedic Group Reports First Quarter Results 5Hanger Orthopedic Group Reports First Quarter Results 6Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 2Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 3Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 4Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 5Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 6Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 7
(Date:3/29/2015)... Chicago, IL (PRWEB) March 29, 2015 ... Foundation for Women’s Cancer announce today that ... 2015 recipient of the Claudia Cohen Research Foundation Prize ... presented at the Society of Gynecologic Oncology 46th Annual ... is Director of the Cedars-Sinai Women’s Cancer Program at ...
(Date:3/29/2015)... 29, 2015 The federal court ... ) pending in the U.S. District Court, Northern ... Case Management Conference for April 21st at 1:30 ... address the progress of product liability claims filed ... attacks, strokes and other cardiovascular complications due to ...
(Date:3/29/2015)... March 29, 2015 Youth Villages will ... in Oregon to assess the feasibility of implementing a ... and behavioral problems and their families. , Third Sector ... participants that will be provided technical assistance throughout 2015 ... join six other national awardees chosen by Third Sector. ...
(Date:3/29/2015)... North American Seminars receives Texas Board Physical Therapy ... . , Utilizing Pilates to Enhance Rehab ... # 56399TX      , The Interactive Shoulder Algorithm ... 10.5 hours - Texas Board of Physical Therapy      ... the SI Joint - 10 hours - Texas Board ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural ... their new natural sunscreen. They are offering the sunscreen ... options come with a bonus lip balm sunscreen. , The ... Click to see the natural sunscreen on Amazon ... is made with non-nano zinc oxide and provides broad-based protection ...
Breaking Medicine News(10 mins):Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3
... Maintains its Top Spot, and Big Pharma Dominates Top ... Thomson,Scientific, part of The Thomson Corporation (NYSE: TOC ... the worldwide research and,business communities, today announced the availability ... Splash?" In this quarterly review of the scientific ...
... populations are an increasing issue for the Western world. The ... has been a rise in older men and women living ... relatives. A new study, funded by the Economic and Social ... a spouse or with others on the health and happiness ...
... favourable clinical outcome in women with ovarian carcinoma, and ... published this week in the online open access journal, ... of peptide hormones, and the receptor GPR54 have previously ... In this study, researchers have shown that kisspeptin and ...
... announced strong sales and earnings for its first,quarter ended September ... per diluted share, on revenues of $2,751,000. This compares to ... revenues of $2,424,000,for the first quarter of last year. ... 13.5% revenue growth, year over year -- Gross margin ...
... N.J., Nov. 14 Roche announced today,that ... has approved MIRCERA,(methoxy polyethylene glycol-epoetin beta) for ... failure (CRF) in adults, including patients,on dialysis ... commonly known as chronic,kidney disease (CKD). MIRCERA ...
... 14 The vast,majority of people required to ... law have failed to do so, according,to an ... Consumer Rights,(FTCR)., A California proposal modeled on ... correct for the affordability crisis faced by,Massachusetts residents. ...
Cached Medicine News:Health News:Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007 2Health News:Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007 3Health News:Living arrangements, health and well-being: A European perspective 2Health News:Predicting the future in ovarian cancer 2Health News:Biotel Announces Strong Results for the First Quarter Ended September 30, 2007, FDA 510(k) Clearance for the Braemar ER900 Wireless Event Recorder 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 3Health News:Consumer Group to Nunez: Massachusetts Mandatory Health Insurance Purchase Law Is No Model for California 2Health News:Consumer Group to Nunez: Massachusetts Mandatory Health Insurance Purchase Law Is No Model for California 3Health News:Consumer Group to Nunez: Massachusetts Mandatory Health Insurance Purchase Law Is No Model for California 4
... When someone suffers an episode of ... right away. The QuikDraw PRO quickly restores ... immediate pain relief.,With just a few sizes ... clothing sizes, the QuikDraw PRO will reduce ...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p...
... Shoulder Immobilizer with Contoured ... Navy cotton sling with foam-padded ... body straps. Quick-release closure buckles. ... 35 covered abduction wedge to ...
... Combining the therapeutic benefits of controlled ... hemarthrosis, swelling, and pain. The anatomically designed ... treatment.,The Shoulder Cryo/Cuff can be ordered with ... to larger chest circumferences.,All Cryo/Cuffs can be ...
Medicine Products: